Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes

被引：0
|
作者：
Song Cang
Ran Liu
Wei Jin
Qi Tang
Wanjun Li
Kunqian Mu
Pengfei Jin
Kaishun Bi
Qing Li
机构：
[1] Shenyang Pharmaceutical University,School of Pharmacy, National and Local Joint Engineering Laboratory for Key Technology of Chinese Material Medica Quality Control
[2] Shenzhen Polytechnic,School of Applied Chemistry and Biological Technology
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[4] Chinese Academy of Medical Science,Department of Pharmaceutical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine
来源：
Chinese Medicine | / 16卷
关键词：
Non-small cell lung cancer; Traditional Chinese medicine syndromes; Syndrome differentiation; Lipidomics; Proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy
    Bar, Jair
    Leibowitz, Raya
    Reinmuth, Niels
    Ammendola, Astrid
    Jacob, Eyal
    Moskovitz, Mor
    Levy-Barda, Adva
    Lotem, Michal
    Katsenelson, Rivka
    Agbarya, Abed
    Abu-Amna, Mahmoud
    Gottfried, Maya
    Harkovsky, Tatiana
    Wolf, Ido
    Tepper, Ella
    Loewenthal, Gil
    Yellin, Ben
    Brody, Yehuda
    Dahan, Nili
    Yanko, Maya
    Lahav, Coren
    Harel, Michal
    Raveh Shoval, Shani
    Elon, Yehonatan
    Sela, Itamar
    Dicker, Adam P.
    Shaked, Yuval
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [23] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Yanjun Xu
    Zhiyu Huang
    Xiaoqing Yu
    Kaiyan Chen
    Yun Fan
    Molecular Brain, 14
  • [24] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Xu, Yanjun
    Huang, Zhiyu
    Yu, Xiaoqing
    Chen, Kaiyan
    Fan, Yun
    MOLECULAR BRAIN, 2021, 14 (01)
  • [25] Surgery in patients with non-small cell lung cancer (NSCLC):: An analysis of 133 patients
    Skricková, J
    Babicková, L
    Kaplanová, J
    Kubová, O
    Pálková, I
    Tomísková, M
    Svobodník, A
    Spelda, S
    Koptíková, J
    Merta, Z
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 169 - 173
  • [26] A Meta Analysis on Prognostic Value of Patients with Non-Small Cell Lung Cancer
    Rui, Jiang
    Li Yingping
    Gu, Lijun
    Wang, Zhiyan
    Zuo, Jing
    Zha, Lin
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2018, 8 (09) : 1875 - 1880
  • [27] Multiparametric analysis of prognosis in patients with advanced non-small cell lung cancer
    Stefan, Holdenrieder
    von, Pawel J.
    Raith, H.
    Feldmann, K.
    Stenman, U. H.
    Nagel, D.
    Stieber, P.
    TUMOR BIOLOGY, 2006, 27 : 40 - 40
  • [28] A retrospective analysis of non-small cell lung cancer patients treated with nivolumab
    Akagi, Kazumasa
    Honda, Noritaka
    Umeyama, Yasuhiro
    Ogawara, Daiki
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Kitazaki, Takeshi
    Nakatomi, Katsumi
    Fukuda, Minoru
    Mukae, Hiroshi
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Urine test for EGFR analysis in patients with non-small cell lung cancer
    Franovic, Aleksandra
    Raymond, Victoria M.
    Erlander, Mark G.
    Reckamp, Karen L.
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1323 - S1331
  • [30] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
12345